Solution nuclear magnetic resonance spectroscopy techniques for probing intermolecular interactions.
暂无分享,去创建一个
[1] Nicola Mongelli,et al. Reliable high-throughput functional screening with 3-FABS. , 2004, Drug discovery today.
[2] R. Freeman,et al. Projection-reconstruction of three-dimensional NMR spectra. , 2003, Journal of the American Chemical Society.
[3] K. Pervushin,et al. Impact of Transverse Relaxation Optimized Spectroscopy (TROSY) on NMR as a technique in structural biology , 2000, Quarterly Reviews of Biophysics.
[4] Christopher W Murray,et al. Fragment-based lead discovery using X-ray crystallography. , 2005, Journal of medicinal chemistry.
[5] R. London,et al. The inter-ligand Overhauser effect: A powerful new NMR approach for mapping structural relationships of macromolecular ligands , 1999, Journal of biomolecular NMR.
[6] R. Glockshuber,et al. Pilus chaperone FimC–adhesin FimH interactions mapped by TROSY-NMR , 1999, Nature Structural Biology.
[7] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[8] L. Kay,et al. Solution NMR spectroscopy beyond 25 kDa. , 1997, Current opinion in structural biology.
[9] K. Wüthrich,et al. Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS , 2002, Journal of biomolecular NMR.
[10] I D Campbell,et al. Studies of protein-ligand interactions by NMR. , 2003, Biochemical Society transactions.
[11] A. Gronenborn,et al. Theory of the time dependent transferred nuclear Overhauser effect: Applications to structural analysis of ligand-protein complexes in solution , 1983 .
[12] MECHANISTIC STUDIES OF AN ANTIBODY-CATALYZED PERICYCLIC REARRANGEMENT , 1998 .
[13] P. Hajduk,et al. NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. , 1997, Journal of medicinal chemistry.
[14] Ajay,et al. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. , 1999, Chemistry & biology.
[15] Daniel A Erlanson,et al. Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly. , 2004, Current opinion in chemical biology.
[16] R. Riek,et al. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] Bernd Meyer,et al. Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.
[18] Maurizio Pellecchia,et al. Use of selective Trp side chain labeling to characterize protein-protein and protein-ligand interactions by NMR spectroscopy. , 2003, Journal of the American Chemical Society.
[19] S. Züger,et al. Intein-based biosynthetic incorporation of unlabeled protein tags into isotopically labeled proteins for NMR studies , 2005, Nature Biotechnology.
[20] N. Dixon,et al. Optimization of an Escherichia coli system for cell-free synthesis of selectively N-labelled proteins for rapid analysis by NMR spectroscopy. , 2004, European journal of biochemistry.
[21] Ray Freeman,et al. Fast multi-dimensional Hadamard spectroscopy. , 2003, Journal of magnetic resonance.
[22] Maurizio Pellecchia,et al. SAR by ILOEs: an NMR-based approach to reverse chemical genetics. , 2006, Chemistry.
[23] L. Kay,et al. A novel approach for sequential assignment of proton, carbon-13, and nitrogen-15 spectra of larger proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin , 1990 .
[24] D. Kern,et al. The role of dynamics in allosteric regulation. , 2003, Current opinion in structural biology.
[25] L. Kay,et al. A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin. , 1990, Biochemistry.
[26] Nicola Mongelli,et al. A general NMR method for rapid, efficient, and reliable biochemical screening. , 2003, Journal of the American Chemical Society.
[27] D. Wyss,et al. Structures of protein-protein complexes are docked using only NMR restraints from residual dipolar coupling and chemical shift perturbations. , 2002, Journal of the American Chemical Society.
[28] Wim G. J. Hol,et al. Structural genomics for science and society , 2000, Nature Structural Biology.
[29] Kurt Wüthrich,et al. Nmr in drug discovery , 2002, Nature Reviews Drug Discovery.
[30] Gregg Siegal,et al. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery. , 2005, Chemistry & biology.
[31] Jeffrey W. Peng,et al. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design. , 2004, Journal of synchrotron radiation.
[32] Ray Freeman,et al. Reconstruction of the three-dimensional NMR spectrum of a protein from a set of plane projections , 2003, Journal of biomolecular NMR.
[33] Stephen W. Fesik,et al. One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules , 1997 .
[34] N. Shimba,et al. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment , 2003, Nature Structural Biology.
[35] Timothy F. Havel,et al. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN. , 1987, Journal of molecular biology.
[36] J. Prestegard,et al. Residual dipolar couplings in structure determination of biomolecules. , 2004, Chemical reviews.
[37] P. Güntert. Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.
[38] W. Jahnke,et al. Spin label enhanced NMR screening. , 2001, Journal of the American Chemical Society.
[39] Maurizio Pellecchia,et al. Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox. , 2004, Chemistry & biology.
[40] M Ikura,et al. An efficient 3D NMR technique for correlating the proton and15N backbone amide resonances with the α-carbon of the preceding residue in uniformly15N/13C enriched proteins , 1991, Journal of biomolecular NMR.
[41] Thomas Szyperski,et al. Reduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Taylor‐Papadimitriou,et al. NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3. , 2002, European journal of biochemistry.
[43] Jean M. Severin,et al. Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR , 1997 .
[44] L. Kay,et al. The use of 2H, 13C, 15N multidimensional NMR to study the structure and dynamics of proteins. , 1998, Annual review of biophysics and biomolecular structure.
[45] A. Bax. Weak alignment offers new NMR opportunities to study protein structure and dynamics , 2003, Protein science : a publication of the Protein Society.
[46] Hideo Takahashi,et al. A novel NMR method for determining the interfaces of large protein–protein complexes , 2000, Nature Structural Biology.
[47] Margaret A. Johnson,et al. NMR spectroscopic and molecular modeling studies of protein-carbohydrate and protein-peptide interactions. , 2004, Carbohydrate research.
[48] D. Sem,et al. SEA-TROSY (solvent exposed amides with TROSY): a method to resolve the problem of spectral overlap in very large proteins. , 2001, Journal of the American Chemical Society.
[49] Alexander Shekhtman,et al. Semisynthesis of a segmental isotopically labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the N-extein-intein junction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Korsmeyer,et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.
[51] Maurizio Pellecchia,et al. Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. , 2004, Chemistry & biology.
[52] J. Waltho,et al. Double and triple resonance NMR methods for protein assignment. , 1997, Methods in molecular biology.
[53] Claudio Dalvit,et al. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. , 2003, Journal of the American Chemical Society.
[54] W. Moore. Maximizing discovery efficiency with a computationally driven fragment approach. , 2005, Current opinion in drug discovery & development.
[55] Jeffrey W. Peng,et al. Theory and applications of NMR-based screening in pharmaceutical research. , 2004, Chemical reviews.
[56] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[57] H. Schwalbe,et al. Cross-correlated relaxation for measurement of angles between tensorial interactions. , 2001, Methods in enzymology.
[58] Stephen W. Fesik,et al. The Use of Differential Chemical Shifts for Determining the Binding Site Location and Orientation of Protein-Bound Ligands , 2000 .
[59] Wolfgang Jahnke,et al. Second-Site NMR Screening with a Spin-Labeled First Ligand , 2000 .
[60] L. Kay,et al. NMR methods for the study of protein structure and dynamics. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[61] Maurizio Pellecchia,et al. NMR-based structural characterization of large protein-ligand interactions , 2002, Journal of biomolecular NMR.
[62] B. Meyer,et al. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. , 2001, Journal of the American Chemical Society.
[63] Renaldo Mendoza,et al. NMR-Based Screening of Proteins Containing 13C-Labeled Methyl Groups , 2000 .
[64] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.
[65] M. Sundström,et al. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water* , 2000, Journal of biomolecular NMR.
[66] Jens Klein,et al. DETECTING BINDING AFFINITY TO IMMOBILIZED RECEPTOR PROTEINS IN COMPOUND LIBRARIES BY HR-MAS STD NMR , 1999 .
[67] Christopher W Murray,et al. Fragment-based lead discovery: leads by design. , 2005, Drug discovery today.
[68] Daniel A Erlanson,et al. Tethering: fragment-based drug discovery. , 2004, Annual review of biophysics and biomolecular structure.
[69] Dawoon Jung,et al. Efficient synthetic inhibitors of anthrax lethal factor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[70] Ray Freeman,et al. Fast reconstruction of four-dimensional NMR spectra from plane projections , 2004, Journal of biomolecular NMR.
[71] D Cowburn,et al. Segmental isotopic labeling using expressed protein ligation. , 2001, Methods in enzymology.
[72] L. Kay,et al. A robust and cost-effective method for the production of Val, Leu, Ile (δ1) methyl-protonated 15N-, 13C-, 2H-labeled proteins , 1999, Journal of biomolecular NMR.
[73] Dawoon Jung,et al. NMR-based techniques in the hit identification and optimisation processes , 2004, Expert opinion on therapeutic targets.
[74] Gaetano T Montelione,et al. Automated protein fold determination using a minimal NMR constraint strategy , 2003, Protein science : a publication of the Protein Society.
[75] S. Grzesiek,et al. 1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma. , 1992, Biochemistry.
[76] T. O'Brien,et al. Fragment-based drug discovery. , 2004, Journal of medicinal chemistry.
[77] Ray Freeman,et al. Projection-reconstruction technique for speeding up multidimensional NMR spectroscopy. , 2004, Journal of the American Chemical Society.
[78] H. Jhoti,et al. The Discovery of Novel Protein Kinase Inhibitors by Using Fragment‐Based High‐Throughput X‐ray Crystallography , 2005, Chembiochem : a European journal of chemical biology.
[79] Hugo O Villar,et al. Using NMR for ligand discovery and optimization. , 2004, Current opinion in chemical biology.
[80] M. Congreve,et al. Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.
[81] Kurt Wüthrich,et al. NOBEL LECTURE: NMR Studies of Structure and Function of Biological Macromolecules , 2003, Bioscience reports.
[82] K Wüthrich,et al. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. , 1980, Biochemical and biophysical research communications.
[83] Edward R Zartler,et al. Fragonomics: fragment-based drug discovery. , 2005, Current opinion in chemical biology.
[84] B. Malmström. Nobel Lectures in Chemistry 1991 – 1995 , 1997 .
[85] V. Stojanoff,et al. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. , 1999, Science.
[86] I. Solomon. Relaxation Processes in a System of Two Spins , 1955 .
[87] G. Bodenhausen,et al. Principles of nuclear magnetic resonance in one and two dimensions , 1987 .
[88] T. Muir,et al. Segmental isotopic labeling for structural biological applications of NMR. , 2004, Methods in molecular biology.
[89] Timothy F. Havel,et al. Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry. , 1985, Journal of molecular biology.
[90] Markus Schade,et al. NMR fragment screening: tackling protein-protein interaction targets. , 2005, Current opinion in drug discovery & development.
[91] Dawoon Jung,et al. Discovery of a novel class of reversible non-peptide caspase inhibitors via a structure-based approach. , 2005, Journal of medicinal chemistry.
[92] K Wüthrich. Nuclear magnetic resonance studies of internal mobility in globular proteins. , 1981, Biochemical Society symposium.